Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_assertion type Assertion NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_head.
- NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_provenance.
- NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_assertion evidence source_evidence_literature NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_provenance.
- NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_assertion SIO_000772 14601054 NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_provenance.
- NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_assertion wasDerivedFrom befree-20140225 NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_provenance.
- NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_assertion wasGeneratedBy ECO_0000203 NP331574.RAXUGVUn1kQ-g-MYsFHiHrwEou9LQpbRo-Eg8q2MEmL80130_provenance.